- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biomea Fusion Inc (BMEA)
Biomea Fusion Inc stock price live, this page displays NASDAQ BMEA stock exchange data. View the BMEA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biomea Fusion Inc real time stock price chart below.
What Is the Biomea Fusion Inc Stock Price Today?
The Biomea Fusion Inc stock price today is 1.96.
What Is the Stock Symbol for Biomea Fusion Inc?
The stock symbol for Biomea Fusion Inc is "BMEA."
What Stock Exchange Does Biomea Fusion Inc Trade On?
Biomea Fusion Inc is listed and trades on the NASDAQ stock exchange.
Is Biomea Fusion Inc a Good Stock to Buy?
Determining whether Biomea Fusion Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BMEA quote. (ISIN: US09077A1060)
What Is the Biomea Fusion Inc Stock Price Today?
The Biomea Fusion Inc stock price today is 1.96.
What Is the Stock Symbol for Biomea Fusion Inc?
The stock symbol for Biomea Fusion Inc is "BMEA."
What Stock Exchange Does Biomea Fusion Inc Trade On?
Biomea Fusion Inc is listed and trades on the NASDAQ stock exchange.
Is Biomea Fusion Inc a Good Stock to Buy?
Determining whether Biomea Fusion Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BMEA quote. (ISIN: US09077A1060)
NASDAQ
Currency in USD
1.96
+0.10(+5.38%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.90
2.03
52 wk Range
1.29
13.07
BMEA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BMEA is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.902.03
52 wk Range
1.2913.07
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BMEA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
13.14
Upside
+570.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Biomea Fusion Company Profile
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It’s lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.
Biomea Fusion Inc SWOT Analysis
Clinical Breakthroughs | Explore Biomea Fusion's promising results in acute leukemia and diabetes treatments, with BMF-500 showing efficacy in 11 out of 12 patients in Phase I trials |
Financial Landscape | Despite a healthy current ratio of 3.39, Biomea faces challenges with ongoing losses and rapid cash burn, typical for early-stage biotech companies |
Market Dynamics | Biomea's counter-market behavior (beta -0.28) offers portfolio diversification, while its focus on genetic cancers and metabolic diseases targets significant unmet needs |
Future Catalysts | Analyst targets range from $9 to $19, with upcoming Phase 2 data for BMF-219 in diabetes expected by December 2025, potentially driving valuation changes |
Compare BMEA to Peers and Sector
Metrics to compare | BMEA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBMEAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −3.8x | −0.5x | |
PEG Ratio | −1.33 | 0.02 | 0.00 | |
Price/Book | 4.0x | 2.4x | 2.6x | |
Price / LTM Sales | - | 9.3x | 3.1x | |
Upside (Analyst Target) | - | 154.2% | 47.8% | |
Fair Value Upside | Unlock | 10.6% | 6.9% | Unlock |
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 13.14
(+570.55% Upside)
Earnings
Latest Release
May 05, 2025
EPS / Forecast
-0.80 / -0.9172
Revenue / Forecast
-- / --
FAQ
What Is the Biomea Fusion (BMEA) Stock Price Today?
The Biomea Fusion stock price today is 1.96.
What Stock Exchange Does Biomea Fusion Trade On?
Biomea Fusion is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Biomea Fusion?
The stock symbol for Biomea Fusion is "BMEA."
What Is the Biomea Fusion Market Cap?
As of today, Biomea Fusion market cap is 113.47M.
What Is Biomea Fusion's Earnings Per Share (TTM)?
The Biomea Fusion EPS (TTM) is -3.54.
When Is the Next Biomea Fusion Earnings Date?
Biomea Fusion will release its next earnings report on 03 Aug 2025.
From a Technical Analysis Perspective, Is BMEA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Biomea Fusion Stock Split?
Biomea Fusion has split 0 times.
How Many Employees Does Biomea Fusion Have?
Biomea Fusion has 79 employees.
What is the current trading status of Biomea Fusion (BMEA)?
As of 09 Jul 2025, Biomea Fusion (BMEA) is trading at a price of 1.96, with a previous close of 1.86. The stock has fluctuated within a day range of 1.90 to 2.03, while its 52-week range spans from 1.29 to 13.07.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.